¼¼°èÀÇ ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀå
Medical Polyoxymethylene
»óǰÄÚµå : 1787129
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 280 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀåÀº 2030³â±îÁö 3¾ï 2,550¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 2¾ï 4,280¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 2,550¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠȣ¸ðÆú¸®¸Ó POM´Â CAGR 5.1%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 480¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÄÚÆú¸®¸Ó POM ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 4.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6,620¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¾î Áß±¹Àº CAGR 8.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀåÀº 2024³â¿¡ 6,620¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.0%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð°¡ 6,460¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.4%¿Í 5.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾Æ¼¼Å» ¶Ç´Â Æú¸®¾Æ¼¼Å»·Îµµ ¾Ë·ÁÁø Æú¸®¿Á½Ã¸ÞÆ¿·»(POM)Àº °í°­µµ, Ä¡¼ö ¾ÈÁ¤¼º, Àú¸¶Âû¼º, ¿ì¼öÇÑ ³»È­ÇмºÀ¸·Î ÀÎÇØ ÀÇ·á »ê¾÷¿¡¼­ ³Î¸® »ç¿ëµÇ´Â °í¼º´É ¿£Áö´Ï¾î¸µ ÇÃ¶ó½ºÆ½ÀÔ´Ï´Ù. Á¤¹ÐÀÇ·á ºÎǰ, ±Ý¼Ó ºÎǰÀÇ °æ·® ´ëüǰ, °í³»±¸¼º ÀÇ·áÀåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó POMÀº ÇコÄɾî Á¦Á¶¿¡ ¾ø¾î¼­´Â ¾È µÉ ¼ÒÀç°¡ µÇ¾ú½À´Ï´Ù. ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·»Àº ¼ö¼ú±â±¸ ¹× ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡¼­ Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ¹× Áø´Ü Àåºñ¿¡ À̸£±â±îÁö ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·»Àº ÀÇ·á ±â¼ú ¹ßÀü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. »ýüÀûÇÕ¼º ó¹æ, ³»¸ê±Õ¼º º¯Çü, ¸¶ÀÌÅ©·Î ¼ºÇü ±â´É µîÀÇ Çõ½ÅÀ¸·Î Æú¸®¿Á½Ã¸ÞÆ¿·»ÀÇ ¿ëµµ´Â ´õ¿í È®´ëµÇ°í ÀÖÀ¸¸ç, Â÷¼¼´ë ÀÇ·á±â±âÀÇ Áß¿äÇÑ ¼ÒÀç°¡ µÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀåÀ» Çü¼ºÇÏ´Â »õ·Î¿î Æ®·»µå´Â?

ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ÀÇ·á±â±â Á¦Á¶¿¡¼­ ±Ý¼Ó¿¡¼­ ÇÃ¶ó½ºÆ½À¸·Î ´ëüÇÏ´Â ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ±âÁ¸¿¡´Â ¼ö¼ú±â±¸, Áø´Ü±â±¸, Á¤Çü¿Ü°ú¿ë ºÎǰÀº ½ºÅ×Àθ®½º ½ºÆ¿À̳ª ƼŸ´½°ú °°Àº ±Ý¼ÓÀ¸·Î ¸¸µé¾îÁ³½À´Ï´Ù. ±×·¯³ª Æú¸®¸Ó ±â¼úÀÇ ¹ßÀü¿¡ µû¶ó °í¼º´É POM ¹èÇÕÀÌ ±Ý¼Ó ºÎǰÀ» ´ëüÇÒ ¼ö ÀÖ´Â °¡º±°í ³»½Ä¼ºÀÌ ¶Ù¾î³ª¸ç ºñ¿ë È¿À²ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ POM ±â¹Ý ÀÇ·á¿ë ºÎǰÀº ¿Ü°ú ÀÇ»çÀÇ »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, Àΰø°üÀý ¹× Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® µîÀÇ ¿ëµµ¿¡¼­ ÇǷθ¦ ÁÙÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â ³»¸ê±Õ¼º°ú »ýüÀûÇÕ¼ºÀÌ ¿ì¼öÇÑ Æú¸®¿Á½Ã¸ÞÆ¿·» µî±Þ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ÀÇ·á »ê¾÷¿¡¼­ Àç·á´Â °¨¸¶¼±, ¿¡Æ¿·»¿Á»çÀ̵å(EtO), Áõ±â ¿ÀÅäŬ·¹ÀÌºê µîÀÇ ¹Ýº¹ÀûÀÎ ¸ê±Õ »çÀÌŬÀ» °ßµô ¼ö ÀÖ¾î¾ß Çϸç, ¿­È­³ª ±â°èÀû ¹«°á¼ºÀ» ÀÒÁö ¾Ê¾Æ¾ß ÇÕ´Ï´Ù. ÃÖ±Ù ¿­Àû, È­ÇÐÀû ¾ÈÁ¤¼ºÀÌ Çâ»óµÈ ÀÇ·á¿ë POM ÄÄÆÄ¿îµåÀÇ ¹ßÀüÀ¸·Î Àç»ç¿ë °¡´ÉÇÑ ¼ö¼ú±â±¸, ¸ê±ÕµÈ Ä¡°ú¿ë ±â±¸, À̽ÄÇü ¾à¹° Àü´Þ ½Ã½ºÅÛ µî¿¡ ¸Å¿ì ÀûÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÇ·á±â±â´Â ¿©·¯ ¹ø ¸ê±ÕÀ» ¹Ýº¹Çصµ ±¸Á¶Àû ¼º´ÉÀ» À¯ÁöÇÒ ¼ö ÀÖ¾î ÀæÀº ±³Ã¼ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á±â±â Á¦Á¶ÀÇ ¸¶ÀÌÅ©·Î ¼ºÇü ¹× Á¤¹Ð ¿£Áö´Ï¾î¸µÀÇ È®´ëµµ ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. Àν¶¸° ÆßÇÁ ºÎǰ, ÈíÀԱ⠱ⱸ, Ä«Å×ÅÍ ºÎǰ µî ÀÇ·á ºÎǰÀÇ ¼ÒÇüÈ­¿¡ µû¶ó Á¦Á¶¾÷üµéÀº POMÀÇ ¿ì¼öÇÑ °¡°ø¼º°ú Ä¡¼ö ¾ÈÁ¤¼ºÀ» Ȱ¿ëÇÏ¿© ÃÊÁ¤¹Ð ¼ÒÇü ÀÇ·á±â±â¸¦ »ý»êÇϰí ÀÖ½À´Ï´Ù. °íÁ¤¹Ð »çÃâ ¼ºÇü ±â¼úÀÇ ÅëÇÕÀ¸·Î °áÇÔÀÌ ÀûÀº º¹ÀâÇÑ ÀÇ·á¿ë ºÎǰÀ» »ý»êÇÒ ¼ö ÀÖ´Â ´É·ÂÀÌ ´õ¿í Çâ»óµÇ¾î ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·ÇϰíÀÚ ÇÏ´Â Á¦Á¶¾÷ü¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·»ÀÇ ¿ëµµ¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

°í¼º´É °íºÐÀÚ È­ÇÕ¹°ÀÇ ±â¼úÀû ¹ßÀüÀº ÀÇ·á ºÐ¾ß¿¡¼­ Æú¸®¿Á½Ã¸ÞÆ¿·»ÀÇ ´É·ÂÀ» Å©°Ô È®´ëÇß½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ µ¹ÆÄ±¸ Áß Çϳª´Â ÀÇ·á¿ë Ç¥¸é¿¡¼­ ¹ÚÅ׸®¾ÆÀÇ Áõ½ÄÀ» Àû±ØÀûÀ¸·Î ¾ïÁ¦ÇÏ´Â Ç×±Õ¼º POM ¹èÇÕ¹° °³¹ßÀÔ´Ï´Ù. Àº ÀÌ¿ÂÀ̳ª ±¸¸® ±â¹ÝÀÇ Ç×±ÕÁ¦¸¦ ¹èÇÕÇÑ ÀÌ·¯ÇÑ Â÷¼¼´ë Æú¸®¸Ó´Â °¨¿° ´ëÃ¥ÀÌ ÃÖ¿ì¼± °úÁ¦ÀÎ º´¿ø ȯ°æ¿¡¼­ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷üµéÀº º´¿ø ³» °¨¿°(HAI)À» ÁÙÀ̰í ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ã۱â À§ÇØ Ç×±Õ POMÀ» Á¢Ã˸é, ¼ö¼ú±â±¸, Ä«Å×ÅÍ ºÎǰ¿¡ Àû¿ëÇϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Å« Çõ½ÅÀº ¹æ»ç¼± ºÒÅõ°ú¼º Æú¸®¿Á½Ã¸ÞÆ¿·»ÀÇ ÅëÇÕÀ¸·Î À̹ÌÁö ÀûÇÕ¼ºÀ» Çâ»ó½ÃŰ´Â °ÍÀÔ´Ï´Ù. ±âÁ¸ÀÇ Æú¸®¸Ó ±â¹Ý ÀÇ·á¿ë ºÎǰÀº X¼±À̳ª MRI ½ºÄµ¿¡¼­ °¡½Ã¼ºÀÌ ¶³¾îÁö´Â °æ¿ì°¡ ¸¹¾Æ Áø´Ü ¿ëµµ·Î´Â »ç¿ëÀÌ Á¦ÇÑÀûÀ̾ú½À´Ï´Ù. ±×·¯³ª Ȳ»ê ¹Ù·ý°ú ÅÖ½ºÅÙÀ» ÷°¡ÇÑ »õ·Î¿î ¹æ»ç¼± ºÒÅõ°ú¼º POM µî±ÞÀÌ °³¹ßµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ÀÇ·á¿ë ¿µ»ó¿¡ ¼±¸íÇÏ°Ô Åõ°úÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Á¤È®ÇÑ ÃßÀû°ú ¹èÄ¡°¡ Áß¿äÇÑ À̽ÄÇü ÀÇ·á±â±â, Ä«Å×ÅÍ ÆÁ, ¼ö¼ú¿ë °¡À̵忡 ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

3D ÇÁ¸°ÆÃ°ú ÀûÃþ °¡°ø ±â¼úÀÇ ¹ßÀüµµ ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀå¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. POMÀº ³ôÀº °áÁ¤µµ¿Í ÈÚ Çö»óÀ¸·Î ÀÎÇØ 3D ÇÁ¸°ÆÃÀÌ ¾î·Á¿üÀ¸³ª, ÃÖ±Ù POM ȣȯ 3D ÇÁ¸°ÆÃ Çʶó¸àÆ®¿Í ¼±ÅÃÀû ·¹ÀÌÀú ¼Ò°á(SLS) °øÁ¤ÀÇ Çõ½ÅÀ¸·Î ¸ÂÃãÇü º¸Ã¶¹°, ȯÀÚº° ÀÓÇöõÆ®, ÀÇ·á±â±âÀÇ ½Å¼ÓÇÑ ÇÁ·ÎÅäŸÀÔ Á¦ÀÛÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÇ·á±â±âÀÇ ½Å¼ÓÇÑ ÇÁ·ÎÅäŸÀÌÇο¡ »õ·Î¿î °¡´É¼ºÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. 3D ÇÁ¸°ÆÃ ±â¼úÀ» ÅëÇØ ȯÀÚº° ÀÇ·á¿ë ºÎǰÀ» ¼Ò·® »ý»êÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÇ·á ºÐ¾ß¿¡¼­ POMÀÇ Ã¤ÅÃÀÌ ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë Æú¸®¿Á½Ã¸ÞÆ¿·» ½ÃÀåÀÇ ¼ºÀåÀº Á¤¹ÐÀÇ·á ºÎǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú Áõ°¡, °íºÐÀÚ »ì±Õ ±â¼úÀÇ ¹ßÀü, ÀÇ·á±â±â Á¦Á¶ÀÇ ¼¼°è È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °í¼º´É, °æ·®, ³»±¸¼ºÀÌ ¶Ù¾î³­ ¼ÒÀç¿¡ ´ëÇÑ ¿ä±¸·Î ÀÎÇØ ÀÇ·á±â±â Á¦Á¶¾÷üµéÀº ±âÁ¸ÀÇ ±Ý¼ÓÀ» POM°ú °°Àº ÀÇ·á¿ë Æú¸®¸Ó·Î ´ëüÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ¼ö¼ú±â±¸ÀÇ ¼ÕÀâÀÌ, Àν¶¸° ÆæÀÇ ¸ÞÄ¿´ÏÁò, ÈíÀԱ⠺Îǰ µîÀÇ ¿ëµµ¿¡ »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

ÃÖ¼Òħ½À ¼ö¼ú Áõ°¡·Î ³»½Ã°æ ±â±â, Ä«Å×ÅÍ ½Ã½ºÅÛ, ·Îº¿ º¸Á¶ ¼ö¼ú Àåºñ¿¡¼­ POM ±â¹Ý ¸¶ÀÌÅ©·Î ÄÄÆ÷³ÍÆ® ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ È¸º¹ ½Ã°£ ´ÜÃà°ú ¼ö¼ú À§Çè °¨¼Ò¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, Á¤¹ÐÇÏ°Ô ¼³°èµÈ ³»¸¶¸ð¼º POM ºÎǰÀÇ °³¹ßÀº Â÷¼¼´ë º¹°­°æ ¼ö¼ú, °üÀý°æ ¼ö¼ú, Ç÷°ü ³» ¼ö¼ú¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

¶Ç ´Ù¸¥ Å« ¿øµ¿·ÂÀº ¾Æ½Ã¾Æ, À¯·´, ºÏ¹Ì¿¡¼­ ÀÇ·á¿ë Æú¸®¸ÓÀÇ »ý»ê ´É·ÂÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¹Ì±¹°ú À¯·´Àº ±ÔÁ¦ ¿ä°ÇÀÌ ¾ö°ÝÇϱ⠶§¹®¿¡ Á¦Á¶¾÷üµéÀº FDA, CE, ISO 10993 Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ISO ÀÎÁõÀ» ȹµæÇÑ ÀÇ·á¿ë Æú¸®¸Ó Á¦Á¶ ½Ã¼³¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå, ƯÈ÷ Àεµ, Áß±¹, ºê¶óÁú¿¡¼­ ÀÇ·á¿ë POMÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇöÁö ÀÇ·á±â±â Á¦Á¶ ¹× ÇコÄɾî ÀÎÇÁ¶ó¸¦ Áö¿øÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêµµ °í±â´É¼º ÀÇ·á¿ë Æú¸®¸Ó ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ģȯ°æÀûÀ̰í ÀçȰ¿ëÀÌ °¡´ÉÇÑ ÀÇ·á¿ë ÇÃ¶ó½ºÆ½¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Áö¼Ó°¡´É¼ºÀÌ Áß¿ä½ÃµÇ¸é¼­ »ýºÐÇØ¼º ¹× ÀçȰ¿ëÀÌ °¡´ÉÇÑ POM ¹èÇÕ¿¡ ´ëÇÑ ¿¬±¸°¡ Ȱ¹ßÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. º´¿ø ³» ÇÃ¶ó½ºÆ½ Æó±â¹°À» ÁÙÀ̱â À§ÇÑ ÀÚÀç ÀçȰ¿ë ÇÁ·Î±×·¥ ¹× Æó¼â ·çÇÁ Á¦Á¶ ½Ã½ºÅÛÀ» ÅëÇÑ ³ë·ÂÀº °í³»±¸¼º POMÀ» »ç¿ëÇÑ ÀúºÎÇÏ, Àç»ç¿ëÀÌ °¡´ÉÇÑ ÀÇ·á¿ë ºÎǰÀÇ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½º¸¶Æ® ÀÇ·á±â±â, Ç×±Õ ÇÃ¶ó½ºÆ½, °íÁ¤¹Ð ¼ö¼ú¿ë ºÎǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Áõ°¡ÇÏ´Â °¡¿îµ¥, Á¤¼¼´Â °è¼Ó ÁøÈ­ÇÏ´Â ÇコÄÉ¾î ±â¼ú¿¡¼­ Áß¿äÇÑ Àç·á·Î ³²À» °ÍÀÔ´Ï´Ù. °íºÐÀÚ °øÇÐ, ±ÔÁ¦ Áؼö ¹× Áö¼Ó°¡´É¼º ºÐ¾ßÀÇ Çõ½ÅÀÌ ÁøÇàµÊ¿¡ µû¶ó ÀÇ·á¿ë POMÀÇ ¹Ì·¡´Â À¯¸ÁÇϸç, Àü ¼¼°è ÷´Ü ÀÇ·á ÀÀ¿ë ºÐ¾ß¿¡ Áö¼ÓÀûÀ¸·Î ÅëÇÕµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

À¯Çü(È£¸ðÆú¸®¸Ó POM, ÄÚÆú¸®¸Ó POM), ¿ëµµ(Åõ¼®±â, ¼ö¼ú ±â±¸¿ë ÇÚµé, ÈíÀÔ±â, Àν¶¸° Ææ, ÀÇ·á¿ë Æ®·¹ÀÌ, ÀǾàǰ¿ë ¸¶°³, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Polyoxymethylene Market to Reach US$325.5 Million by 2030

The global market for Medical Polyoxymethylene estimated at US$242.8 Million in the year 2024, is expected to reach US$325.5 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Homopolymer POM, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Copolymer POM segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$66.2 Million While China is Forecast to Grow at 8.0% CAGR

The Medical Polyoxymethylene market in the U.S. is estimated at US$66.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$64.6 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Medical Polyoxymethylene Market - Key Trends & Drivers Summarized

Polyoxymethylene (POM), also known as acetal or polyacetal, is a high-performance engineering plastic widely used in the medical industry due to its high strength, dimensional stability, low friction, and excellent chemical resistance. As the demand for precision medical components, lightweight replacements for metal parts, and high-durability medical devices grows, POM has become an essential material in healthcare manufacturing. From surgical instruments and drug delivery systems to orthopedic implants and diagnostic equipment, medical-grade polyoxymethylene is playing a crucial role in advancing medical technology. Innovations in biocompatible formulations, sterilization-resistant variants, and micro-molding capabilities are further expanding its applications, making it a key material in next-generation medical devices.

What Emerging Trends Are Shaping the Medical Polyoxymethylene Market?

One of the most significant trends influencing the medical polyoxymethylene market is the increasing preference for metal-to-plastic substitution in medical device manufacturing. Traditionally, surgical instruments, diagnostic tools, and orthopedic components were made from metals such as stainless steel and titanium. However, with advancements in polymer technology, high-performance POM formulations are offering a lighter, corrosion-resistant, and cost-effective alternative to metal components. These POM-based medical components not only improve ease of use for surgeons but also reduce fatigue and enhance patient comfort in applications like prosthetic joints and orthopedic implants.

Another key trend is the growing demand for sterilization-resistant and biocompatible polyoxymethylene grades. In the medical industry, materials must withstand repeated sterilization cycles using gamma radiation, ethylene oxide (EtO), or steam autoclaving without degrading or losing their mechanical integrity. Recent advancements in medical-grade POM compounds with enhanced thermal and chemical stability have made them highly suitable for reusable surgical instruments, sterilized dental devices, and implantable drug delivery systems. These innovations ensure that medical devices maintain their structural performance even after multiple sterilization cycles, reducing the need for frequent replacements.

The expansion of micro-molding and precision engineering in medical device manufacturing is also shaping the market. With the miniaturization of medical components, such as insulin pump parts, inhaler mechanisms, and catheter components, manufacturers are leveraging POM’s excellent machinability and dimensional stability to create ultra-precise, small-scale medical devices. The integration of high-precision injection molding techniques has further enhanced the material’s ability to produce complex medical parts with minimal defects, making it a preferred choice for manufacturers aiming to meet stringent regulatory standards.

How Are Technological Advancements Enhancing the Applications of Medical Polyoxymethylene?

Technological advancements in high-performance polymer compounding have significantly expanded the capabilities of polyoxymethylene in the medical sector. One of the most notable breakthroughs is the development of antimicrobial POM formulations that actively inhibit bacterial growth on medical surfaces. These next-generation polymers, infused with silver-ion or copper-based antimicrobial agents, are becoming increasingly popular in hospital settings, where infection control is a top priority. Medical equipment manufacturers are incorporating antimicrobial POM into touch surfaces, surgical tools, and catheter components to reduce hospital-acquired infections (HAIs) and improve patient safety.

Another major innovation is the integration of radiopaque polyoxymethylene for enhanced imaging compatibility. Traditional polymer-based medical components often lack visibility under X-ray and MRI scans, limiting their use in diagnostic applications. However, new radiopaque POM grades are being developed with barium sulfate and tungsten additives, allowing them to appear clearly in medical imaging. This advancement is particularly valuable for implantable medical devices, catheter tips, and surgical guides, where precise tracking and placement are crucial.

Advancements in 3D printing and additive manufacturing are also transforming the medical polyoxymethylene market. While POM has traditionally been challenging to 3D print due to high crystallinity and warping issues, recent breakthroughs in POM-compatible 3D printing filaments and selective laser sintering (SLS) processes are opening new possibilities for customized prosthetics, patient-specific implants, and rapid prototyping of medical devices. The ability to manufacture low-volume, patient-specific medical components using 3D printing technology is expected to drive further adoption of POM in medical applications.

What Factors Are Driving the Growth of the Medical Polyoxymethylene Market?

The growth in the medical polyoxymethylene market is driven by several factors, including the increasing demand for precision medical components, the rise in minimally invasive surgical procedures, advancements in polymer sterilization technology, and the global expansion of medical device manufacturing. The need for high-performance, lightweight, and durable materials has led medical device manufacturers to replace traditional metals with medical-grade polymers like POM, particularly in applications such as surgical tool handles, insulin pen mechanisms, and inhaler components.

The rising number of minimally invasive surgeries has fueled demand for POM-based micro-components in endoscopic instruments, catheter systems, and robotic-assisted surgical devices. As healthcare systems prioritize shorter recovery times and reduced surgical risks, the development of precision-engineered, friction-resistant POM components is becoming essential for next-generation laparoscopic, arthroscopic, and endovascular procedures.

Another major driver is the expansion of medical polymer production capabilities across Asia, Europe, and North America. With stringent regulatory requirements in the U.S. and Europe, manufacturers are investing in ISO-certified, medical-grade polymer production facilities to ensure compliance with FDA, CE, and ISO 10993 standards. The increasing adoption of medical POM in emerging markets, particularly in India, China, and Brazil, is further fueling global market expansion. Additionally, government initiatives supporting local medical device manufacturing and healthcare infrastructure are expected to boost demand for high-performance medical polymers.

The growing emphasis on eco-friendly and recyclable medical plastics is also driving the market. With sustainability becoming a key focus in healthcare, research into biodegradable and recyclable POM formulations is gaining momentum. Efforts to reduce plastic waste in hospitals through material recycling programs and closed-loop manufacturing systems are encouraging the development of low-impact, reusable medical components made from high-durability POM.

As the demand for smart medical devices, antimicrobial plastics, and high-precision surgical components continues to rise, medical polyoxymethylene is poised to remain a crucial material in the evolving landscape of healthcare technology. With ongoing innovations in polymer engineering, regulatory compliance, and sustainability, the future of medical-grade POM looks promising, ensuring its continued integration into advanced medical applications worldwide.

SCOPE OF STUDY:

The report analyzes the Medical Polyoxymethylene market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Homopolymer POM, Copolymer POM); Application (Dialysis Machine, Handles for Surgical Instruments, Inhalers, Insulin Pen, Medical Trays, Pharmaceutical Closures, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â